189559-85-1 Usage
Uses
Used in Synthetic Chemistry:
Ethanone, 1-(1H-indazol-6-yl)(9CI) is used as a key intermediate for the synthesis of various complex organic molecules. Its unique structure, which includes the indazole group and the carbonyl group, allows for versatile chemical reactions and transformations, making it a valuable component in the creation of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Ethanone, 1-(1H-indazol-6-yl)(9CI) is employed as a building block for the development of new drug candidates. Its structural features enable the design of molecules with potential therapeutic properties, which can be further optimized through medicinal chemistry approaches. Ethanone, 1-(1H-indazol-6-yl)(9CI) serves as a starting point for the synthesis of novel compounds with potential applications in the treatment of various diseases and medical conditions.
Used in Agrochemical Development:
Ethanone, 1-(1H-indazol-6-yl)(9CI) is also utilized in the agrochemical sector as a precursor for the synthesis of new pesticides and other crop protection agents. Its chemical properties allow for the creation of molecules with improved efficacy, selectivity, and environmental compatibility, contributing to the development of more sustainable and effective agricultural solutions.
Used in Materials Science:
In the field of materials science, Ethanone, 1-(1H-indazol-6-yl)(9CI) is explored for its potential applications in the synthesis of advanced materials, such as organic semiconductors, conductive polymers, and other functional materials. Its unique structural features can be exploited to design materials with tailored electronic, optical, and mechanical properties, opening up new possibilities for applications in electronics, energy storage, and other high-tech industries.
Check Digit Verification of cas no
The CAS Registry Mumber 189559-85-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,5,5 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 189559-85:
(8*1)+(7*8)+(6*9)+(5*5)+(4*5)+(3*9)+(2*8)+(1*5)=211
211 % 10 = 1
So 189559-85-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O/c1-6(12)7-2-3-8-5-10-11-9(8)4-7/h2-5H,1H3,(H,10,11)
189559-85-1Relevant academic research and scientific papers
HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 00302; 00303, (2014/06/24)
Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
INDAZOLYL, BENZIMIDAZOLYL, BENZOTRIAZOLYL SUBSTITUTED INDOLMONE DERIVATIVES AS KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER
-
Page/Page column 127, (2009/07/25)
The present invention is directed to a compound is represented by Structural Formula (A):or a pharmaceutically acceptable salt therof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof.
BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS AURORA KINASE INHIBITORS
-
Page/Page column 94-95, (2010/11/28)
The present invention relates to compounds and methods from the treatment of cancer. The invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising compounds that inhibit Aurora kinase, and methods for the treatment of cancer using the compounds of the presentation invention or pharmaceutical compositions comprising compounds of the present invention.
